Concomitant ixekizumab and tirzepatide significantly improved skin clearance and weight reduction in adults with moderate to severe plaque psoriasis.

Pivya ® (pivmecillinam tablets) is now available for the treatment of female patients aged 18 years and older with uncomplicated urinary tract infections (uUTI) caused by susceptible isolates of ...

Phase 3 trial results show remibrutinib significantly improves complete response rates in patients with 3 types of chronic inducible urticaria.

The Food and Drug Administration (FDA) has approved Filkri ® (filgrastim-laha), a biosimilar to Neupogen ® (filgrastim). Filkri, a leukocyte growth factor, is approved to: ...

New FDA approval for Wakix (pitolisant) allows for the treatment of cataplexy in pediatric narcolepsy patients.

Rybrevant Faspro is a subcutaneous co-formulation of amivantamab, a bispecific EGFR-directed and MET receptor-directed antibody, and hyaluronidase.

Inhaled corticosteroids are strongly recommended, in addition to streamlined management with combination and step-up therapy ...

HealthDay News — A baby food product sold across most of the US is being pulled from store shelves after tests found higher-than-expected levels of a toxin linked to mold, federal officials said.

HealthDay News — A recall of frozen tater tots has expanded after federal officials warned that hundreds of thousands of pounds could contain pieces of plastic. The US Food and Drug Administration ...

Strongest and most certain factors were prior allergic conditions within first year of life, allergic rhinitis, wheeze ...

The NDA is supported by data from part A of the phase 2 PROSPECT trial, which evaluated tirabrutinib in 48 adult patients with R/R PCNSL.

These grants “fund a core public health function that serves every single person in the state, city- or county-funded,” Elizabeth Finley, interim director of the National Coalition of STD Directors.